References
- WHO - Respiratory Syncytial Virus (RSV) disease Available at: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/respiratory-syncytial-virus-disease, Accessed 13.07.2023.
- Nam H and Ison M, Respiratory syncytial virus infection in adults, BMJ 2019 Sep 10;366:l5021.
- Shang et al., Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies, Int J Biol Sci 2021 Sep 27;17(14):4073–4091.
- Sun Y and López C, The innate immune response to RSV: Advances in our understanding of critical viral and host factors, Vaccine 2017 Jan 11;35(3):481–488.
- Talbot et al., Respiratory Syncytial Virus in Older Adults. A Hidden Annual Epidemic, Infectious Diseases in Clinical Practice, Nov 2016.
- Cantú-Flores K, Rivera-Alfaro G, Muñoz-Escalante JC, Noyola DE. Global distribution of respiratory syncytial virus A and B infections: a systematic review. Pathog Glob Health. 2022 Oct; 116(7):398–409. doi: 10.1080/20477724.2022.2038053. Epub 2022 Feb 14. PMID: 35156555; PMCID: PMC9518599.
- Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA, Available at https://www.ecdc.europa.eu/sites/default/files/documents/RRA-20221128-473.pdf Accessed 12.07.2023.
- National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases Available at https://www.cdc.gov/rsv/about/transmission.html Accessed 12.07.2023.
- Centers for Disease Control and Prevention. Respiratory Syncytial Virus Infection (RSV). Available at: https://www.cdc.gov/rsv/index.html#:~:text=Respiratory%20syncytial%20(sin%2DSISH%2D,for%20infants%20and%20older%20adults. Accessed 14.07.2023.
- National Collaborating Centre for Infectious Diseases. Respiratory Syncytial Virus (RSV) 2022 Update. Available at: https://nccid.ca/debrief/respiratory-syncytial-virus-rsv/. Accesses 14.07.2023.
- Government of Canada. Pathogen Safety Data Sheets: Infectious Substances – Respiratory syncytial virus. Available at: https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/respiratory-syncytial-virus.html Acccesed 14.07.2023.
- Belongia et al., Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old, Open Forum Infect Dis 2018 Nov 27;5(12).
- Jeannoël et al., Microorganisms associated with respiratory syncytial virus pneumonia in the adult population, Eur J Clin Microbiol Infect Dis 2019 Jan;38(1):157–160;
- Hamilton MA, Liu Y, Calzavara A, et al. Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2. Influenza Other Respir Viruses. Nov 2022;16(6):1072–1081. doi:10.1111/irv.13C04.
- RSV in Adults | American Lung Association Available at: RSV in Adults | American Lung Association Accessed 14.07.2023.
- Falsey et al., Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness J Infect Dis 2014 Jun 15;209(12):1873–8;
- Shang et al., Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies, Int J Biol Sci 2021 Sep 27;17(14):4073–4091.
- Stephens LM, et al., Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population, Vaccines (Basel). 2021;9(6):624.
- Crooke SN, et al., Immunosenescence and human vaccine immune responses, Immun Ageing 2019 Sep 13;16:25.
- RSV Surveillance and Research | CDC Available at: RSV Surveillance and Research | CDC, Accessed 14.07.2023.
- RSV virus expected to add pressure on hospitals in many EU/EEA countries this season (europa.eu) Available at: RSV virus expected to add pressure on hospitals in many EU/EEA countries this season (europa.eu), Accesses 14.07.2023.
- Shi T, Denouel A, Tietjen AK, et al. Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis. Journal of Infectious Diseases. 2020;222(Suppl 7):S577–S583.
- Shi T, Vennard S, Jasiewicz F, Brogden R, Nair H, Investigators R. Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis. J Infect Dis. Aug 12 2022;226(Supplement_1):S17–S21. doi:10.1093/infdis/jiab040.
- Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults. Drugs Aging. 2005;22(7):577–87. doi:10.2165/00002512-200522070-00004.
- People at High Risk for Severe RSV Infection | CDC Available at: People at High Risk for Severe RSV Infection | CDC, Accessed 14.07.2023.
- Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA Available at: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-20221128-473.pdf, Accessed 14.07.2023.
- Branche A, Why Making a Diagnosis of Respiratory Syncytial Virus Should Matter to Clinicians, Clin Infect Dis 2019 Jul 2;69(2):204–206.
- Tin Tin Htar et al., The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis, Epidemiol Infect 2020; 148: e48.
- Tseng HF et al., Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection, J Infect Dis 2020 Sep 14;222(8):1298–1310.
- Zhou Y et al., Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China, Influenza Other Respir Viruses 2020 Sep;14(5):483–490.
- Bosco E et al., Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents, JAMA Netw Open. 2021 Jun; 4(6).
- Riester MR et al., Relationships Between Community Virus Activity and Cardiorespiratory Rehospitalizations From Post-Acute Care, J Am Med Dir Assoc. 2022 Aug; 23(8): 1418–1423. e7.
- Goldman CR et al., Severe Clinical Outcomes Among Adults Hospitalized With Respiratory Syncytial Virus Infections, New York City, 2017-2019, Public Health Rep 2022 Sep-Oct;137(5):929–935.
- CDC-Respiratory Syncytial Virus Infection (RSV), Available at: https://www.cdc.gov/rsv/about/symptoms.html, Accessed 13.07.2023.
- Public Health England. Public Health England. Respiratory syncytial virus (RSV): symptoms, transmission, prevention, treatment. 16 September 2021. https://www.gov.uk/government/publications/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment. Accessed 13 July 2023.
- FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine, Accessed 13.07.2023.
- U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults Available at: https://www.pfizer.com/news/press-release/press-release-detail/us-fda-approves-abrysvotm-pfizers-vaccine-prevention, Accessed 13.07.2023.
- Walsh EE et al. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults, N Engl J Med2023;388:1465–1477.
- Vaccines and Related Biological Products Advisory Committee February 28 - March 1, 2023 Meeting Presentation-Bivalent RSV Prefusion F Vaccine in Adults Over 60 Years of Age Available at https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-february-28-march-1-2023-meeting#event-materials, Accessed 14.07.2023.
- Arexvy SmPC, Available at: arexvy-epar-product-information_en.pdf (europa.eu), Accessed 14.07.2023.
- RSV Vaccine and mAb Snapshot Available at https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/Accessed 14.07.2023.
- Government of Canada. Canada communicable disease report: respiratory syncytial virus (RSV). April 2020. https://www.canada.ca/en/public-health/services/reports-publications/cana-da-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020.html. Accessed 14.07. 2023.
- Government of South Australia. Respiratory syncytial virus (RSV) infection—including symptoms, treatment and prevention. 2021. https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/conditions/infectious+diseases/respiratory+syncytial+virus+rsv+infection/respiratory+syncytial+virus+rsv+infection+-+including+symptoms+treatment+and+prevention. Accessed 14.07. 2023.
- UK Health Security Agency. UK Health Security Agency. Respiratory syncytial virus (RSV): the Green Book, Chapter 27a v2_0. 4 September 2015. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/458469/Green_Book_Chapter_27a_v2_0W.PDF. Accessed 14.07. 2023.
- CDC. US Centers for Disease Control and Prevention. Respiratory syncytial virus: prevention. 2021. https://www.cdc.gov/rsv/about/prevention.html. Accessed 14.07. 2023.
- Respiratory syncytial virus (RSV) immunisation programme: JCVI advice, 7 June 2023, Available at: https://www.gov.uk/government/publications/rsv-immunisation-programme-jcvi-advice-7-june-2023/respiratory-syncytial-virus-rsv-immunisation-programme-jcvi-advice-7-june-2023, Accessed 14.07.2023